Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II

Conditions

• Novel Oral Anticoagulants
• NOACs
• Rivaroxaban
• Apixaban
• Edoxaban
• Dabigatran
• Ticagrelor
• Pharmacodynamics
• Pharmacogenomics
• RNA Profile
• Bleeding
• Biomarker

Interventions

• GENETIC: Detection of genotype and RNA profile in platelet and white blood cell
• OTHER: Indicators test related to coagulation function
• OTHER: Indicators test related to platelet function

Sponsor

Peking University First Hospital